Table 3.
Logistic Regression Analysis of Factor Associated with “Good” Adherence to Treatment
| Variable | Category | Univariate | Multivariate |
|---|---|---|---|
| OR (95% CI); p-Value | OR (95% CI); p-Value | ||
| Age | 0.86 (0.73–1.00); 0.06 | 0.78 (0.61–1.00); 0.05 | |
| Sex | Male vs female | 0.88 (0.39–1.97); 0.75 | - |
| Family history of myopia | None | Ref. | - |
| One parent | 0.84 (0.30–2.41); 0.75 | - | |
| Two parents | 1.38 (0.44–4.34); 0.58 | - | |
| Type of therapy | Atropine | Ref. | Ref. |
| DIMS spectacle lenses | 11.25 (2.38–53.26); 0.002 | 21.17 (2.84–157.66); 0.003 | |
| Combined treatment: DIMS spectacle lenses + atropine | 4.75 (1.41–15.99); 0.012 | 4.02 (1.08–15.02); 0.038 | |
| Defocus contact lenses | 9.50 (1.15–78.42); 0.037 | 9.59 (1.00–92.02); 0.05 | |
| Combined treatment: DIMS spectacle lenses + defocus contact lenses | 2.13 (0.60–7.52); 0.24 | 3.03 (0.59–15.67); 0.19 | |
| Red light treatment | 0.33 (0.05–2.23); 0.26 | 0.32 (0.03–3.37); 0.34 | |
| Previous treatment | 1.41 (0.50–3.99); 0.52 | - | |
| Treatment duration | 0.66 (0.51–0.86); 0.002 | 0.74 (0.51–1.06); 0.10 | |
| Baseline cycloplegic SE | 1.01 (0.84–1.21); 0.96 | ||
| Myopia progression in SE OD | 0.31 (0.14–0.72); 0.006 | 0.16 (0.05–0.51); 0.002 |
Notes: Factors associated with good adherence (≥75%) to myopia-control treatment; comparisons are vs the other categories. “Ref.” indicates the reference category.
Abbreviations: CI, confidence interval; D, diopters; DIMS, Defocus Incorporated Multiple Segments; OR, odds ratio; SE, spherical equivalent.